Myasthenia Gravis News and Research

RSS
Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by varying degrees of weakness of the skeletal (voluntary) muscles of the body. The hallmark of myasthenia gravis is muscle weakness that increases during periods of activity and improves after periods of rest. Muscles that control eye and eyelid movements, facial expression, chewing, talking, and swallowing are often, but not always, involved. The muscles that control breathing and neck and limb movements may also be affected. Myasthenia gravis is caused by a defect in the transmission of nerve impulses to muscles. Normally when impulses travel down the nerve, the nerve endings release a neurotransmitter substance called acetylcholine. In myasthenia gravis, antibodies produced by the body's own immune system block, alter, or destroy the receptors for acetylcholine. The first noticeable symptoms of myasthenia gravis may be weakness of the eye muscles, difficulty in swallowing, or slurred speech. Symptoms vary in type and severity. Myasthenia gravis is not directly inherited nor is it contagious.
Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Gait analysis in animals: Treadmill versus non treadmill system

Gait analysis in animals: Treadmill versus non treadmill system

Unlocking the power of proteins to better understand human health

Unlocking the power of proteins to better understand human health

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

The effects and mechanisms of SARS-CoV-2 on the nervous system

The effects and mechanisms of SARS-CoV-2 on the nervous system

Study finds increased risk of neurodegenerative disorders among COVID-19 positive patients

Study finds increased risk of neurodegenerative disorders among COVID-19 positive patients

Type I interferons play crucial role in fending off SARS-CoV-2

Type I interferons play crucial role in fending off SARS-CoV-2

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

Current evidence that vitamin D is effective against COVID-19 neurological sequelae

TTUHSC expert wins NIH renewal grant to continue research on neurological disorders

TTUHSC expert wins NIH renewal grant to continue research on neurological disorders

New research shines light on mysterious dynamics that define the interplay between nerves and muscle

New research shines light on mysterious dynamics that define the interplay between nerves and muscle

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Black patients with systemic sclerosis may experience poorer outcomes more often than others

Black patients with systemic sclerosis may experience poorer outcomes more often than others

Dying patients with rare diseases struggle to get experimental therapies

Dying patients with rare diseases struggle to get experimental therapies

Study fills crucial knowledge gaps on myasthenia gravis

Study fills crucial knowledge gaps on myasthenia gravis

How COVID-19 affects the nervous system

How COVID-19 affects the nervous system

Parenting your aging parents when they don’t want help

Parenting your aging parents when they don’t want help

Influenza vaccine found to be safe for people with autoimmune neuromuscular disorders

Influenza vaccine found to be safe for people with autoimmune neuromuscular disorders

UM launches CAR-T clinical trial for patients with myasthenia gravis

UM launches CAR-T clinical trial for patients with myasthenia gravis

GW researchers to study the underlying pathophysiology of myasthenia gravis

GW researchers to study the underlying pathophysiology of myasthenia gravis

NIH grants boost rare diseases research efforts

NIH grants boost rare diseases research efforts